Comparison
3 Methylglutaconic Aciduria Type Viia C5676967 vs 3 4 Toe Cutaneous Syndactyly C5937396
Clinical comparison between 3 Methylglutaconic Aciduria Type Viia and 3 4 Toe Cutaneous Syndactyly for differential diagnosis and treatment planning.
3 Methylglutaconic Aciduria Type Viia C5676967
A rare inherited metabolic disorder affecting mitochondrial function. It typically appears in infancy with developmental delay, movement problems, and muscle weakness. Management focuses on supportive care and addressing specific symptoms.
3 4 Toe Cutaneous Syndactyly C5937396
Skin webbing between the third and fourth toes, typically present at birth. Usually harmless and often left untreated unless it causes problems.
6 comparison axes
Onset
3 Methylglutaconic Aciduria Type Viia C5676967
0-2
3 4 Toe Cutaneous Syndactyly C5937396
0-0
Onset patterns differ
Severity
3 Methylglutaconic Aciduria Type Viia C5676967
severe
3 4 Toe Cutaneous Syndactyly C5937396
mild
Different severity levels
Chronic
3 Methylglutaconic Aciduria Type Viia C5676967
Chronic
3 4 Toe Cutaneous Syndactyly C5937396
Chronic
Differing course
Communicable
3 Methylglutaconic Aciduria Type Viia C5676967
No
3 4 Toe Cutaneous Syndactyly C5937396
No
Different transmission
Body System
3 Methylglutaconic Aciduria Type Viia C5676967
metabolic
3 4 Toe Cutaneous Syndactyly C5937396
musculoskeletal
Same/different system
Category
3 Methylglutaconic Aciduria Type Viia C5676967
metabolic
3 4 Toe Cutaneous Syndactyly C5937396
other
Different category
Bottom line
3-methylglutaconic-aciduria-type-viia-C5676967 and 3-4-toe-cutaneous-syndactyly-C5937396 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Methylglutaconic Aciduria Type Viia C5676967 | 3 4 Toe Cutaneous Syndactyly C5937396 | Discriminating power |
|---|---|---|---|
| Developmental delay | Often reported in infancy with the metabolic disorder | Not a feature of isolated toe webbing | High |
| Toe appearance | No characteristic third-fourth toe webbing described | Skin fusion between the third and fourth toes from birth | High |
| Muscle weakness or movement problems | May occur with mitochondrial dysfunction | Not expected from isolated cutaneous syndactyly | Moderate |
When to favor each condition
Choose 3 Methylglutaconic Aciduria Type Viia C5676967 when
Infant with developmental delay and movement problems
Fits the described metabolic presentation better than a toe finding
Moderate
Suspected inherited mitochondrial disorder
Source describes mitochondrial involvement and supportive care
Moderate
Systemic rather than local foot concern
Metabolic category and severe course distinguish it
High
Choose 3 4 Toe Cutaneous Syndactyly C5937396 when
Isolated skin webbing of third and fourth toes
Matches the congenital musculoskeletal description
High
No developmental or neuromuscular concerns
Isolated syndactyly is usually harmless
Moderate
Cosmetic or footwear issue only
Treatment is optional unless function is affected
Moderate
How key tests differ
| Test | 3 Methylglutaconic Aciduria Type Viia C5676967 | 3 4 Toe Cutaneous Syndactyly C5937396 | Interpretation |
|---|---|---|---|
| Clinical examination | Neurologic or developmental findings may be present | Visible skin bridge between toes | Exam separates systemic disease from a local anomaly |
| Metabolic or genetic evaluation | May be considered when this disorder is suspected | Not indicated for isolated syndactyly | Do not treat an abnormal result as a diagnosis without clinician review |
| Imaging of the foot | No specific foot imaging pattern established | May clarify soft-tissue versus bony involvement if needed | Use only when anatomy or function is uncertain |
Prognosis comparison
3 Methylglutaconic Aciduria Type Viia C5676967
- Outcome
- Potentially serious chronic course; exact prognosis is not established here
- Factors
- Symptom severity and supportive needs
3 4 Toe Cutaneous Syndactyly C5937396
- Outcome
- Usually benign and stable
- Factors
- Whether function, hygiene, or footwear is affected
Time frame: From birth or infancy onward
Clinician assessment determines individual outlook
Complications comparison
| Complication | Presentation |
|---|---|
| Functional limitation | Possible developmental and motor impairment Usually little or no functional limitation Severity differs markedly |
| Need for intervention | Supportive symptom management may be ongoing Often untreated unless problems arise Intervention depends on symptoms |
| Associated systemic disease | Mitochondrial disorder implies broader effects Isolated finding is not itself systemic disease Look for additional features before linking them |
Patient education highlights
- HighDifferent conditions
These findings involve different body systems and should not be assumed related.
- MediumWhen to seek care
Report developmental delay, weakness, or toe problems affecting walking or footwear.
- LowTreatment expectations
Metabolic care is supportive; syndactyly is often observed unless troublesome.